| 1 | Double-blind placebo-controlled trial of fluoxetine in adolescents with comorbid major depression and an alcohol use disorder.
| UW Link |
| 2 | A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders.
| Free Link |
| 3 | Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia.
| UW Link |
| 4 | Fluoxetine in adolescents with comorbid major depression and an alcohol use disorder: A five-year follow-up study.
| ADAI/UW Link |
| 5 | Study of the efficacy of fluoxetine and clomipramine in the treatment of premature ejaculation after opioid detoxification.
| ADAI/UW Link |
| 6 | Acute phase and five-year follow-up study of fluoxetine in adolescents with major depression and a comorbid substance use disorder: a review.
| UW Link |
| 7 | Fluoxetine dependence in a former amineptine abuser.
| ADAI/UW Link |
| 8 | Double-blind placebo-controlled trial of fluoxetine in smoking cessation treatment including nicotine patch and cognitive-behavioral group therapy.
| ADAI/UW Link |
| 9 | Fluoxetine in adolescents with comorbid major depression and an alcohol use disorder: a 3-year follow-up study.
| UW Link |
| 10 | Fluoxetine attenuates adrenocortical but not subjective responses to cocaine cues.
| ADAI/UW Link |
| 11 | Fluoxetine in adolescents with major depression and an alcohol use disorder: an open-label trial.
| UW Link |
| 12 | Mass media representations as drug information for patients: the prozac phenomenon.
| ADAI/UW Link |
| 13 | Fluoxetine treatment of cocaine-dependent patients with major depressive disorder.
| UW Link |
| 14 | Fluoxetine versus placebo in depressed alcoholics: a 1-year follow-up study.
| UW Link |
| 15 | Combination pharmacotherapy: a mixture of small doses of naltrexone, fluoxetine, and a thyrotropin-releasing hormone analogue reduces alcohol intake in three strains of alcohol-preferring rats.
| UW Link |
| 16 | The effects of fluoxetine combined with nicotine inhalers in smoking cessation--a randomized trial.
| UW Link |
| 17 | Comparison of the effects of the selective serotonin-reuptake inhibitors fluoxetine, paroxetine, citalopram and fluvoxamine in alcohol-preferring cAA rats.
| UW Link |
| 18 | Fluoxetine versus placebo for the marijuana use of depressed alcoholics.
| UW Link |
| 19 | A treatment algorithm for attention deficit hyperactivity disorder in cocaine-dependent adults : a one-year private practice study with long-acting stimulants, fluoxetine, and bupropion.
| ADAI/UW Link |
| 20 | A randomized trial of adding fluoxetine to a naltrexone treatment programme for heroin addicts.
| UW Link |
| 21 | Fluoxetine treatment of depressive disorders in methadone-maintained opioid addicts.
| UW Link |
| 22 | Combination of naltrexone and fluoxetine on rats' propensity to take alcoholic beverage.
| UW Link |
| 23 | Additive reduction of alcohol drinking by 5-HT1A antagonist WAY 100635 and serotonin uptake blocker fluoxetine in alcohol-preferring P rats.
| UW Link |
| 24 | Fluoxetine treatment seems to reduce the beneficial effects of cognitive-behavioral therapy in type B alcoholics.
| |
| 25 | Desipramine, amantadine, or fluoxetine in buprenorphine-maintained cocaine users.
| UW Link |
| 26 | The chemistry of mood : A look at the phenomenal impact brain chemistry, serotonin, and drugs such as Prozac are having on the treatment of anxiety, depression, and other disorders.
Norden MJ
Professional Counselor 1997;12(1):27-32 (Journal) [ ] | |
| 27 | A controlled trial of fluoxetine in crack cocaine dependence.
| UW Link |
| 28 | A placebo-controlled, double-blind study of fluoxetine in severe alcohol dependence: adjunctive pharmacotherapy during and after inpatient treatment.
| |
| 29 | Effects of combined fluoxetine and counseling in the outpatient treatment of cocaine abusers.
| ADAI/UW Link |
| 30 | Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence : Two placebo-controlled double-blind trials.
| |
| 31 | Fluoxetine improves outcome in addicted patients treated with opioid antagonists.
| ADAI/UW Link |
| 32 | Fluoxetine treatment for dually diagnosed methadone maintained opioid addicts: a pilot study.
| ADAI/UW Link |
| 33 | Ethanol consumption following acute treatment with methysergide, fluoxetine, fenfluramine, and their combination.
| |
| 34 | Ethanol intake of chickens treated with fenfluramine, fluoxetine, and dietary tryptophan.
| |
| 35 | Fluoxetine treatment of nonparaphilic sexual addictions and paraphilias in men.
| |
| 36 | Effect of fluoxetine on alcohol consumption in male alcoholics.
| |
| 37 | Fluoxetine for cocaine abuse in methadone patients: preliminary findings.
| Free Link |
| 38 | Fluoxetine-induced suicidality, serotonin, and seasonality.
Brewerton TD
Biol Psychiatry 1991;30:190-6 (Reprint 04900) [ ] | |
| 39 | Fluoxetine treatment of cocaine abuse in heroin addicts.
| |
| 40 | Fluoxetine and obsessive-compulsive disorder: a naturalistic study.
| |
| 41 | Effects of fluoxetine and desipramine on palatability-induced ethanol consumption in the alcohol-nonpreferring (NP) line of rats.
| |
| 42 | Fluoxetine and bulimia.
| |
| 43 | Effects of fluoxetine on the intragastric self-administration of ethanol in the alcohol preferring P line of rats.
| |